A Vaccine is Almost Ready


COVID-19 vaccinations are just around the corner for designated high-risk groups. (Image source: Air Force Medical Service)

After months of craziness in the world, a vaccine for COVID-19 is finally coming together. Right now, there have been more than 70.8 million cases worldwide and 1.59 million deaths.

There have been quite a few vaccine candidates, but AstraZeneca, a pharmaceutical company, says its experimental vaccine developed along with the University of Oxford has shown 70% efficacy in its results. Another vaccine candidate, Moderna, is said to be 94% effective and strongly protects against serious illness. Based on these results, Moderna planned to submit an application for emergency use authorization to the Food and Drug Administration on November 30. Out of 30,000 volunteers, only 11 got COVID-19.

The FDA said that they are going to assure that the vaccine is safe and effective and that they won’t be cutting corners when it comes to giving a vaccine to millions of people. On December 17, Moderna expects the FDA to be ready to attend a public meeting to discuss the data of Moderna’s vaccine, which could be approved shortly afterwards. Pfizer’s vaccine was evaluated on December 10 and seems to be set for approval. Americans will receive the vaccine as early as the second week in December, according to Moncef Slaoui, White House vaccine chief. The earliest the FDA could authorize the vaccine is December 11.

General Gustave Perna, Chief Operating Officer of Operation Warp Speed, said that vaccine distribution will begin within 24 hours after the authorization is issued. The vaccine will be shipped to all 50 states that same day.